Quest Diagnostics Statistics
Share Statistics
Quest Diagnostics has 111.64M
shares outstanding. The number of shares has increased by -0.1%
in one year.
| Shares Outstanding | 111.64M |
| Shares Change (YoY) | -0.1% |
| Shares Change (QoQ) | -0.57% |
| Owned by Institutions (%) | 89.04% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,484 |
| FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 3.5M, so 3.13% of the outstanding
shares have been sold short.
| Short Interest | 3.5M |
| Short % of Shares Out | 3.13% |
| Short % of Float | 3.58% |
| Short Ratio (days to cover) | 1.93 |
Valuation Ratios
The PE ratio is 19.23 and the forward
PE ratio is 16.77.
Quest Diagnostics's PEG ratio is
6.95.
| PE Ratio | 19.23 |
| Forward PE | 16.77 |
| PS Ratio | 1.7 |
| Forward PS | 1.6 |
| PB Ratio | 2.47 |
| P/FCF Ratio | 18.42 |
| PEG Ratio | 6.95 |
Financial Ratio HistoryEnterprise Valuation
Quest Diagnostics has an Enterprise Value (EV) of 23.28B.
| EV / Sales | 2.36 |
| EV / EBITDA | 12.29 |
| EV / EBIT | 17.45 |
| EV / FCF | 25.61 |
Financial Position
The company has a current ratio of 1.1,
with a Debt / Equity ratio of 1.05.
| Current Ratio | 1.1 |
| Quick Ratio | 1.02 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 3.74 |
| Debt / FCF | 7.8 |
| Interest Coverage | 5.96 |
Financial Efficiency
Return on Equity is 12.85% and Return on Invested Capital is 6.92%.
| Return on Equity | 12.85% |
| Return on Assets | 5.39% |
| Return on Invested Capital | 6.92% |
| Revenue Per Employee | $179,490.91 |
| Profits Per Employee | $15,836.36 |
| Employee Count | 55,000 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 35.26 |
Taxes
| Income Tax | 273M |
| Effective Tax Rate | 23.23% |
Stock Price Statistics
The stock price has increased by 27.33% in the
last 52 weeks. The beta is 0.53, so Quest Diagnostics's
price volatility has been higher than the market average.
| Beta | 0.53 |
| 52-Week Price Change | 27.33% |
| 50-Day Moving Average | 170.32 |
| 200-Day Moving Average | 159.15 |
| Relative Strength Index (RSI) | 57.57 |
| Average Volume (20 Days) | 1,336,952 |
Income Statement
In the last 12 months, Quest Diagnostics had revenue of 9.87B
and earned 871M
in profits. Earnings per share was 7.8.
| Revenue | 9.87B |
| Gross Profit | 3.24B |
| Operating Income | 1.35B |
| Net Income | 871M |
| EBITDA | 1.89B |
| EBIT | 1.4B |
| Earnings Per Share (EPS) | 7.8 |
Full Income StatementBalance Sheet
The company has 549M in cash and 7.09B in
debt, giving a net cash position of -6.54B.
| Cash & Cash Equivalents | 549M |
| Total Debt | 7.09B |
| Net Cash | -6.54B |
| Retained Earnings | 9.36B |
| Total Assets | 15.8B |
| Working Capital | 634M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 1.33B
and capital expenditures -425M, giving a free cash flow of 909M.
| Operating Cash Flow | 1.33B |
| Capital Expenditures | -425M |
| Free Cash Flow | 909M |
| FCF Per Share | 8.19 |
Full Cash Flow StatementMargins
Gross margin is 32.86%, with operating and profit margins of 13.63% and 8.82%.
| Gross Margin | 32.86% |
| Operating Margin | 13.63% |
| Pretax Margin | 11.9% |
| Profit Margin | 8.82% |
| EBITDA Margin | 19.19% |
| EBIT Margin | 13.63% |
| FCF Margin | 9.21% |
Dividends & Yields
DGX pays an annual dividend of $3.8,
which amounts to a dividend yield of 1.86%.
| Dividend Per Share | $3.80 |
| Dividend Yield | 1.86% |
| Dividend Growth (YoY) | 5.63% |
| Payout Ratio | 47.98% |
| Earnings Yield | 5.2% |
| FCF Yield | 5.43% |
Dividend DetailsAnalyst Forecast
The average price target for DGX is $185,
which is 5.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $185 |
| Price Target Difference | 5.2% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock ForecastsStock Splits
The last stock split was on Jun 21, 2005. It was a
forward
split with a ratio of 2:1.
| Last Split Date | Jun 21, 2005 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 3.19 |
| Piotroski F-Score | 6 |
